These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28640869)

  • 41. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
    Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
    Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells.
    Warkiani ME; Khoo BL; Tan DS; Bhagat AA; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
    Analyst; 2014 Jul; 139(13):3245-55. PubMed ID: 24840240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Label-Free Isolation and mRNA Detection of Circulating Tumor Cells from Patients with Metastatic Lung Cancer for Disease Diagnosis and Monitoring Therapeutic Efficacy.
    Wang J; Lu W; Tang C; Liu Y; Sun J; Mu X; Zhang L; Dai B; Li X; Zhuo H; Jiang X
    Anal Chem; 2015 Dec; 87(23):11893-900. PubMed ID: 26531886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with Cytokeratin 19-derived CYFRA21-1 and pathological staging.
    Chen Q; Ge F; Cui W; Wang F; Yang Z; Guo Y; Li L; Bremner RM; Lin PP
    Clin Chim Acta; 2013 Apr; 419():57-61. PubMed ID: 23415723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer.
    Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B
    J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic impact of circulating tumor cells in patients with small cell lung cancer.
    Naito T; Tanaka F; Ono A; Yoneda K; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Kenmotsu H; Shukuya T; Kaira K; Koh Y; Endo M; Hasegawa S; Yamamoto N
    J Thorac Oncol; 2012 Mar; 7(3):512-9. PubMed ID: 22258473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients.
    Wu C; Hao H; Li L; Zhou X; Guo Z; Zhang L; Zhang X; Zhong W; Guo H; Bremner RM; Lin P
    J Thorac Oncol; 2009 Jan; 4(1):30-6. PubMed ID: 19096303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating tumor cell detection using a parallel flow micro-aperture chip system.
    Chang CL; Huang W; Jalal SI; Chan BD; Mahmood A; Shahda S; O'Neil BH; Matei DE; Savran CA
    Lab Chip; 2015 Apr; 15(7):1677-88. PubMed ID: 25687986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of circulating tumor cells from lung cancer patients using microfluidic chip.
    Qian C; Wu S; Chen H; Zhang X; Jing R; Shen L; Wang X; Ju S; Jia C; Cong H
    Clin Exp Med; 2018 May; 18(2):191-202. PubMed ID: 29445889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib.
    Messaritakis I; Politaki E; Koinis F; Stoltidis D; Apostolaki S; Plataki M; Dermitzaki EK; Georgoulias V; Kotsakis A
    Sci Rep; 2018 Feb; 8(1):2238. PubMed ID: 29396560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
    Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
    Bobek V; Gurlich R; Eliasova P; Kolostova K
    World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment.
    Messaritakis I; Nikolaou M; Politaki E; Koinis F; Lagoudaki E; Koutsopoulos A; Georgoulia N; Georgoulias V; Kotsakis A
    Lung Cancer; 2018 Oct; 124():270-278. PubMed ID: 30268472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.
    Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT
    Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH.
    Li Y; Ma G; Zhao P; Fu R; Gao L; Jiang X; Hu P; Ren T; Wu Y; Wang Z; Cui Z; Yang D
    Clin Chim Acta; 2018 Oct; 485():95-102. PubMed ID: 29940145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.
    Xu W; Wu B; Fu L; Chen J; Wang Z; Huang F; Chen J; Zhang M; Zhang Z; Lin J; Lan R; Chen R; Chen W; Chen L; Hong J; Zhang W; Ding Y; Okunieff P; Lin J; Zhang L
    Oncol Rep; 2017 Jun; 37(6):3219-3226. PubMed ID: 28498481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups.
    Awe JA; Saranchuk J; Drachenberg D; Mai S
    Urol Oncol; 2017 May; 35(5):300-309. PubMed ID: 28202223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.
    Lou J; Ben S; Yang G; Liang X; Wang X; Ni S; Han B
    PLoS One; 2013; 8(12):e80458. PubMed ID: 24324600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.